The effect of hydroalcoholic extract of coriander seed on primary dysmenorrhea

Phase 3

Recruiting

Conditions: primary dysmenorrhea.
Primary dysmenorrhea
N94.4

Registration Number: IRCT20230315057729N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 70

Inclusion Criteria

Be single
Be in the age range of 18-30 years
Have regular menstrual cycles
Have moderate to severe dysmenorrhea
Do not have a history of pelvic and abdominal disease
Do not have a history of chronic diseases
Do not have a history of pain in the abdomen and back except during menstrual bleeding
Do not have a history of confirmed mental illnesses
Not having severe mental stress in the last 6 months
Not allergic to coriander
Informed consent to participate in the study

Exclusion Criteria

Unwillingness to continue cooperation
The occurrence of a severe stressful event during the study period
Taking contraceptives
Irregular use of medicine or placebo in the amount of two consecutive doses
Getting married during the study period
Performing professional sports activities
Taking any type of supplement and multivitamin
Presence of benign breast or uterine cysts
They have had a history of prostate cancer, breast cancer and ovarian cancer in their first degree relatives
Use of other herbs or drugs effective on dysmenorrhea

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity and duration of pain in early painful menstruation. Timepoint: Measuring the intensity and duration of painful menstruation at the end of menstrual bleeding during two consecutive cycles and simultaneously with the start of the drug or placebo. Method of measurement: Questionnaires made by the researcher. Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
The amount of menstrual bleeding - duration of menstrual bleeding - physical symptoms associated with menstruation. Timepoint: After the end of menstrual bleeding in two consecutive cycles and at the same time as giving medicine or placebo. Method of measurement: Questionnaires made by the researcher.